Leeds cancer fighter is back in the saddle

Leeds cancer fighter is back in the saddle
He may have had cancer twice but that’s not going to stop Rob George on his next fundraising feat.

Read more on Yorkshire Evening Post

Related posts

Terra med Alliance News US anger at new age rules for breast cancer tests

 

Terra med Alliance News Doctors and experts are in uproar over new recommendations to raise the age of breast cancer screening, warning more women will die from the disease which already claims some 40,000 lives each year.

Terra med Alliance News : Doctors and experts are in uproar over new recommendations to raise the age of breast cancer screening, warning more women will die from the disease which already claims some 40,000 lives each year.

The high-level United States Preventative Services Task Force of scientists and researchers Monday recommended that breast cancer screening in women should now start at the age of 50 as opposed to 40.

» Read more: Terra med Alliance News US anger at new age rules for breast cancer tests

Related posts

New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors

Primitive neuroectodermal tumors (PNETs) arise from undifferentiated brain cells and are the most frequent malignant brain tumors in children. There are different forms of PNETs and, while scientists have made progress in characterizing the genetic abnormalities associated with some PNET subtypes, the highly aggressive cerebral tumors known as CNS-PNETs have been difficult to characterize as they represent a relatively uncommon group of tumors with ill-defined diagnostic features.

“Lack of insight into the molecular pathogenesis of CNS-PNET is a major obstacle towards development of disease-specific models and treatments for these frequently fatal malignancies,” explains senior study author, Dr. Annie Huang from the Hospital for Sick Children in Ontario, Canada. To comprehensively define relevant genetic alterations associated with CNS-PNET, Dr. Huang established international collaborations with colleagues from pediatric oncology centers in Asia, Europe and the United States to complete a sophisticated high resolution genomic screen of a large collection of primary tumors.

» Read more: New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors

Related posts